Skip to search formSkip to main contentSkip to account menu

DPC 817

Known as: DPC-817, DPC817 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

dexelvucitabine
elvucitabine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Emerging anti-HIV drugs.
There are now exactly 20 anti-HIV drugs licenced (approved) for clinical use, and > 30 anti-HIV compounds under (pre)clinical… 
Review
2005
Review
2005
Emerging anti-HIV drugs
There are now exactly 20 anti-HIV drugs licenced (approved) for clinical use, and > 30 anti-HIV compounds under (pre)clinical… 
2003
2003
HIV-1 Resistance Profile of the Novel Nucleoside Reverse Transcriptase Inhibitor β-D-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine (Reverset™)
Nucleoside reverse transcriptase inhibitors (NRTIs) represent the cornerstone of highly active antiretroviral therapy when… 
Highly Cited
2002
Highly Cited
2002
Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry.
A novel analytical method has been developed for direct quantification of intracellular nucleoside triphosphates (NTPs). Lysates… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)